Wayne S. DeVeydt - 21 Mar 2025 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Reporting relationship: Exec Chairman of the Board, Director
Issuer ticker: SGRY
Reported as of: 21 Mar 2025
Net transaction value: +$102,481
SEC form: 4
Accepted by SEC: 25 Mar 2025, 16:32:57 UTC
Prior SEC filing: 03 Jan 2025
Next SEC filing: 02 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Baldock, Attorney-in-Fact

Key filing fact

Wayne S. DeVeydt filed Form 4 for Surgery Partners, Inc. (SGRY) on 25 Mar 2025.

Key facts

This page summarizes Wayne S. DeVeydt's Form 4 filing for Surgery Partners, Inc. (SGRY).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Mar 2025, 16:32.

Change

Previous filing in this sequence was filed on 03 Jan 2025.
Current net transaction value: +$102,481.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGRY transaction

Common Stock

Award

Transaction value: $102,481
Shares: +4,233
Change %: +4.2%
Price: $24.21
Shares after: 105,203
Date: 21 Mar 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock awards ("RSAs") granted to the reporting person on March 21, 2025 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.